tramiprosate

Small moleculeexperimental

Homotaurine, also known as tramiprosate (INN), 3-amino-1-propanesulfonic acid, or 3-APS, is a natural sulfonic acid found in seaweed. It is analogous to taurine, but with an extra carbon in its chain. It has GABAergic activity, apparently by mimicking GABA, which it resembles. — Wikipedia

Clinical trial activity

4 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
0

Earliest trial started Feb 1, 2003 (NCT00056238)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

NCCCS(=O)(=O)O
Mol. weight
139.18 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-penten-3-one, 1,1'-(1,4-phenylene)bis(5-(diethylamino))-4,4-dimethyl-, dihydrobromide, (e,e)-
  • 3-amino-1-propanesulfonic acid
  • 3-aminopropanesulfonic acid
  • 3-aminopropylsulfonic acid
  • 3aps
  • 3aps
  • 3-aps
  • homotaurine
  • nc758
  • nc 758
  • nc-758
  • nc-758
  • nc-758
  • nc-758
  • tramiprosate
  • tramiprosate
  • tramiprosate
  • tramiprosate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00314912Phase 3May 1, 2006Bellus Health Inc
NCT00217763Phase 3Sep 1, 2005Bellus Health Inc, University of Toulouse
NCT00088673Phase 3Jun 1, 2004Bellus Health Inc
NCT00056238Phase 2Feb 1, 2003Bellus Health Inc, Harvard University, National Institute of Neurological Disorders and Stroke (NINDS)
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Bellus Health IncFor profit4422003
Harvard UniversityAcademic/Hospital1012003
National Institute of Neurological Disorders and Stroke (NINDS)Government1012003
University of ToulouseAcademic/Hospital1012005
4 organizations
Page 1 / 1